Health and Fitness

FDA Approves First Generic Version of EpiPen

Silver Spring, Maryland—(ENEWSPF)—August 16, 2018
Contact: Angela Stark
The U.S. Food and Drug Administration today approved the first generic version of EpiPen and EpiPen Jr (epinephrine) auto-injector for the emergency treatment of allergic reactions, including those that are life-threatening (anaphylaxis), in adults and pediatric patients who weigh more than 33 pounds. Teva Pharmaceuticals USA gained approval to market its generic epinephrine auto-injector in 0.3 mg and 0.15 mg strengths.

“Today’s approval of the first generic version of the most-widely prescribed epinephrine . . .

Please follow & like us :)

ARCHIVES